Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altamar Private Equity is a Spanish private markets investment manager and management company historically focused on private equity and alternative investment funds rather than developing therapeutics or healthcare products. The legal entity "ALTAMAR PRIVATE EQUITY, S.G.I.I.C., S.A." appears in CNMV records as a venture capital management company that was deregistered on February 19, 2016. The broader AltamarCAM group remains active as an independent private asset manager and solutions provider with strategies spanning private equity, infrastructure, real estate, venture capital, and related alternatives. While the group has invested in healthcare- and life-science-related vehicles, Altamar Private Equity itself is not a biotech, pharma, or healthcare operating company. It is best characterized as a financial sponsor and fund manager.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altamar Private Equity.